These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advances in Ophthalmic Optogenetics: Approaches and Applications. Prosseda PP; Tran M; Kowal T; Wang B; Sun Y Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770 [TBL] [Abstract][Full Text] [Related]
5. A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision. Chemi G; Brindisi M; Brogi S; Relitti N; Butini S; Gemma S; Campiani G Future Med Chem; 2019 Mar; 11(5):463-487. PubMed ID: 30907134 [TBL] [Abstract][Full Text] [Related]
6. Optogenetic approaches to restoring visual function in retinitis pigmentosa. Busskamp V; Roska B Curr Opin Neurobiol; 2011 Dec; 21(6):942-6. PubMed ID: 21708457 [TBL] [Abstract][Full Text] [Related]
7. Restoring vision using optogenetics without being blind to the risks. Harris AR; Gilbert F Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):41-45. PubMed ID: 34724112 [TBL] [Abstract][Full Text] [Related]
8. Retinal optogenetic therapies: clinical criteria for candidacy. Jacobson SG; Sumaroka A; Luo X; Cideciyan AV Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195 [TBL] [Abstract][Full Text] [Related]
10. Optogenetic Therapy for Visual Restoration. Sakai D; Tomita H; Maeda A Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371 [TBL] [Abstract][Full Text] [Related]
11. Optogenetics for visual restoration: From proof of principle to translational challenges. Lindner M; Gilhooley MJ; Hughes S; Hankins MW Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861 [TBL] [Abstract][Full Text] [Related]
12. Optogenetic approaches to therapy for inherited retinal degenerations. De Silva SR; Moore AT J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243 [TBL] [Abstract][Full Text] [Related]
13. Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy. Provansal M; Marazova K; Sahel JA; Picaud S Transl Vis Sci Technol; 2022 Jan; 11(1):18. PubMed ID: 35024784 [TBL] [Abstract][Full Text] [Related]
14. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa. Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147 [No Abstract] [Full Text] [Related]